Intelligent Medicine Acquisition Corp.: Nasdaq/NYSE listing notice — Nasdaq notifies Intelligent Medicine Acquisition Corp of delisting for unpaid fees and insufficient publicly held shares

Intelligent Medicine Acquisition Corp.

Received Nasdaq letter on March 30, 2023 citing unpaid fees of $140,000 and failure to meet minimum 1,100,000 publicly held shares.
Non-compliance stems from 20,009,861 shares redeemed at Feb 8, 2023 special meeting.
Trading suspension set for April 11, 2023 unless appeal is filed; company intends to request hearing.
Delisting would lead to Form 25-NSE filing with SEC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Intelligent Medicine Acquisition Corp. received a nasdaq noncompliance notice notice regarding other (rules 5450(b)(2)(B)).

Exchange: nasdaq
Notice: noncompliance notice
Rules: 5450(b)(2)(B)

Exact text from the filing

March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Intelligent Medicine Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5250(f), 5450(b)(2)(B), 5810(c)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5250(f), 5450(b)(2)(B), 5810(c)(2)(A)

Exact text from the filing

March 30, 2023, Intelligent Medicine Acquisition Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications division (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $140,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 11, 2023 and a Form

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-042169

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.